Alzamend Neuro, Inc. · NASDAQ:ALZN
Alzamend Neuro, Inc. financial statements
Alzamend Neuro, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Research and development | 3.63M | 1.41M | 6.46M | 7.45M | 5.20M | 1.31M | 1.07M |
| Operating income | -8.77M | -4.50M | -9.94M | -14.9M | -12.3M | -4.95M | -4.42M |
| Depreciation and amortization | 110.7K | 50.7K | 50.7K | 23.1K | 3.55K | ||
| EBITDA | -8.66M | -4.45M | -9.89M | -14.8M | -12.3M | ||
| Interest expense | 6.62K | 18.0K | 10.1K | 7.70K | 46.5K | 142.4K | |
| Income before tax | -8.77M | -4.51M | -9.95M | -14.9M | -12.4M | -5.05M | -4.41M |
| Net income | -8.77M | -4.51M | -9.95M | -14.9M | -12.4M | -5.05M | -4.41M |
| Earnings per share, basic | -2.63 | -11.32 | -132.33 | -22.89 | -0.14 | -0.07 | -0.06 |
| Earnings per share, diluted | -2.63 | -11.32 | -132.33 | -22.89 | -0.14 | -0.07 | -0.06 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 710.7K | 3.95M | 376.0K | 5.14M | 14.1M | 1.93M | 90.3K |
| Current assets | 1.76M | 4.18M | 455.2K | 5.84M | 14.4M | 2.91M | 1.81M |
| Property, plant and equipment | 314.9K | 425.6K | 176.3K | 79.8K | 102.9K | ||
| Total assets | 2.08M | 4.60M | 631.6K | 5.92M | 14.5M | 2.91M | 1.81M |
| Accounts payable | 2.93M | 2.87M | 1.16M | 503.6K | 929.6K | ||
| Current liabilities | 2.87M | 1.16M | 899.6K | 992.3K | |||
| Total liabilities | 1.35M | 634.8K | 3.23M | 2.87M | 1.16M | 899.6K | |
| Shareholders' equity | 733.2K | 3.97M | -2.59M | 3.05M | 13.4M | 2.01M | 821.7K |
| Shares outstanding | 4.26M | 778.7K | 76.4K | 646.3K | 95.5M | 67.4M | 64.8M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -8.07M | -6.57M | -8.27M | -8.92M | -6.61M | -2.71M | -2.35M |
| Cash from investing | -300.0K | -147.2K | -106.5K | 100.9K | 105.0K | ||
| Cash from financing | 4.83M | 10.4M | 3.65M | 200 | 18.9M | 4.45M | 2.29M |
| Change in cash | -3.24M | 3.57M | -4.76M | -8.92M | 12.1M |